On vaccination programs in the EU Member States: the case of the human papilloma virus Reyes LorenteFernando Antonanzas Editorial 07 December 2016 Pages: 801 - 803
Healthier lifestyles after retirement in Europe? Evidence from SHARE Martina CelidoniVincenzo Rebba Original Paper 26 September 2016 Pages: 805 - 830
Measuring customer preferences in the German statutory health insurance Jonas B. PendzialekDusan SimicStephanie Stock Original Paper 21 September 2016 Pages: 831 - 845
The social cost of chronic kidney disease in Italy Giuseppe TurchettiS. Bellelli On Behalf of the Tuscany CKD Study Group Original Paper Open access 03 October 2016 Pages: 847 - 858
Does drug price-regulation affect healthcare expenditures? Omer Ben-AharonOren ShavitRacheli Magnezi Original Paper Open access 30 September 2016 Pages: 859 - 867
Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort Dmitrij AchelrodJonas SchreyöggTom Stargardt Original Paper Open access 03 October 2016 Pages: 869 - 882
The social cost of drugs in France in 2010 Pierre KoppMarysia Ogrodnik Original Paper 08 October 2016 Pages: 883 - 892
Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany Peter GrevenVanja SikiricaCharles Makin Original Paper Open access 05 November 2016 Pages: 893 - 904
The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program Anne NeumannLars LindholmFredrik Norström Original Paper Open access 02 December 2016 Pages: 905 - 919
Age effects in mortality risk valuation Raul BreyJose Luis Pinto-Prades Original Paper 07 December 2016 Pages: 921 - 932